ATE529116T1 - Verfahren zur verstärkung des therapeutischen ansprechens auf elektrokonvulsive therapie (ect) - Google Patents
Verfahren zur verstärkung des therapeutischen ansprechens auf elektrokonvulsive therapie (ect)Info
- Publication number
- ATE529116T1 ATE529116T1 AT03726554T AT03726554T ATE529116T1 AT E529116 T1 ATE529116 T1 AT E529116T1 AT 03726554 T AT03726554 T AT 03726554T AT 03726554 T AT03726554 T AT 03726554T AT E529116 T1 ATE529116 T1 AT E529116T1
- Authority
- AT
- Austria
- Prior art keywords
- ect
- therapeutic response
- enhancement
- electroconvulsive therapy
- electroconvulsive
- Prior art date
Links
- 238000002635 electroconvulsive therapy Methods 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 230000004797 therapeutic response Effects 0.000 title abstract 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 2
- 102000003676 Glucocorticoid Receptors Human genes 0.000 abstract 1
- 108090000079 Glucocorticoid Receptors Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960000890 hydrocortisone Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37681402P | 2002-04-29 | 2002-04-29 | |
| US10/411,503 US7326697B2 (en) | 2002-04-29 | 2003-04-08 | Methods for increasing the therapeutic response to electroconvulsive therapy |
| PCT/US2003/013498 WO2003092790A2 (en) | 2002-04-29 | 2003-04-28 | Methods for increasing the therapeutic response to electroconvulsive therapy ('ect') |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE529116T1 true ATE529116T1 (de) | 2011-11-15 |
Family
ID=29406770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03726554T ATE529116T1 (de) | 2002-04-29 | 2003-04-28 | Verfahren zur verstärkung des therapeutischen ansprechens auf elektrokonvulsive therapie (ect) |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7326697B2 (de) |
| EP (1) | EP1499321B1 (de) |
| JP (2) | JP2005526843A (de) |
| KR (1) | KR100970834B1 (de) |
| CN (1) | CN100438875C (de) |
| AT (1) | ATE529116T1 (de) |
| AU (1) | AU2003228783B2 (de) |
| CA (1) | CA2483855C (de) |
| ES (1) | ES2375356T3 (de) |
| IL (2) | IL164793A0 (de) |
| MX (1) | MXPA04010705A (de) |
| NO (1) | NO335006B1 (de) |
| NZ (1) | NZ536248A (de) |
| PT (1) | PT1499321E (de) |
| WO (1) | WO2003092790A2 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
| US8097606B2 (en) * | 2003-07-23 | 2012-01-17 | Corcept Therapeutics, Inc. | Antiglucocorticoids for the treatment of catatonia |
| WO2007058780A2 (en) * | 2005-11-10 | 2007-05-24 | Electrocore, Inc. | Electrical stimulation treatment of bronchial constriction |
| US9037247B2 (en) | 2005-11-10 | 2015-05-19 | ElectroCore, LLC | Non-invasive treatment of bronchial constriction |
| US20110125203A1 (en) * | 2009-03-20 | 2011-05-26 | ElectroCore, LLC. | Magnetic Stimulation Devices and Methods of Therapy |
| US8812112B2 (en) * | 2005-11-10 | 2014-08-19 | ElectroCore, LLC | Electrical treatment of bronchial constriction |
| US8041428B2 (en) * | 2006-02-10 | 2011-10-18 | Electrocore Llc | Electrical stimulation treatment of hypotension |
| US7711430B2 (en) | 2006-02-10 | 2010-05-04 | Electrocore Llc | Methods and apparatus for treating anaphylaxis using electrical modulation |
| JP2009525806A (ja) * | 2006-02-10 | 2009-07-16 | エレクトロコア、インコーポレイテッド | 低血圧の電気刺激治療 |
| US20100241188A1 (en) * | 2009-03-20 | 2010-09-23 | Electrocore, Inc. | Percutaneous Electrical Treatment Of Tissue |
| EP1987814A1 (de) * | 2007-04-30 | 2008-11-05 | Exelgyn | Pharmazeutische Mifepristonzusammensetzungen und Herstellungsverfahren dafür |
| US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
| EP2320821B2 (de) | 2008-05-09 | 2020-12-30 | Nuvaira, Inc. | Vorrichtungen zur behandlung eines bronchialbaums |
| CN104856757B (zh) | 2009-10-27 | 2017-06-23 | 赫莱拉公司 | 具有可冷却的能量发射组件的递送装置 |
| EP4111995A1 (de) | 2009-11-11 | 2023-01-04 | Nuvaira, Inc. | Vorrichtung zur gewebebehandlung und stenosekontrolleti |
| US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
| WO2012129305A1 (en) * | 2011-03-23 | 2012-09-27 | Pop Test Cortisol Llc | Combination therapy |
| US10500216B2 (en) | 2011-11-18 | 2019-12-10 | Corcept Therapeutics, Inc. | Optimizing mifepristone absorption |
| US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
| US9943526B2 (en) | 2015-04-21 | 2018-04-17 | Corcept Therapeutics, Inc. | Optimizing mifepristone levels for cushing's patients |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4296206A (en) | 1980-04-30 | 1981-10-20 | United States Of America | Irreversible anti-glucocorticoids |
| ZA8231B (en) | 1981-01-09 | 1982-11-24 | Roussel Uclaf | New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained |
| FR2598421B1 (fr) | 1986-05-06 | 1988-08-19 | Roussel Uclaf | Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant |
| US4873981A (en) | 1988-10-14 | 1989-10-17 | Somatics, Inc. | Electroconvulsive therapy apparatus and method for automatic monitoring of patient seizures |
| FR2757400B1 (fr) * | 1996-12-19 | 1999-12-17 | Hoechst Marion Roussel Inc | Application des composes antiglucocorticoides dans le traitement des psychoses ou des comportements addictifs |
| AU747956B2 (en) * | 1997-10-06 | 2002-05-30 | Board Of Trustees Of The Leland Stanford Junior University | Methods for treating psychosis associated with glucocorticoid related dysfunction |
| CA2328411C (en) | 1998-05-15 | 2008-12-16 | Alan F. Schatzberg | Glucocorticoid receptor antagonists for the treatment of dementia |
| US8015648B2 (en) * | 2002-12-18 | 2011-09-13 | Koninklijke Philips Electronics N.V. | System for removably joining a driven member to a driven member with workpiece |
-
2003
- 2003-04-08 US US10/411,503 patent/US7326697B2/en not_active Expired - Lifetime
- 2003-04-28 EP EP03726554A patent/EP1499321B1/de not_active Expired - Lifetime
- 2003-04-28 AT AT03726554T patent/ATE529116T1/de active
- 2003-04-28 MX MXPA04010705A patent/MXPA04010705A/es active IP Right Grant
- 2003-04-28 CN CNB038133318A patent/CN100438875C/zh not_active Expired - Fee Related
- 2003-04-28 CA CA2483855A patent/CA2483855C/en not_active Expired - Fee Related
- 2003-04-28 IL IL16479303A patent/IL164793A0/xx unknown
- 2003-04-28 KR KR1020047017463A patent/KR100970834B1/ko not_active Expired - Fee Related
- 2003-04-28 WO PCT/US2003/013498 patent/WO2003092790A2/en not_active Ceased
- 2003-04-28 AU AU2003228783A patent/AU2003228783B2/en not_active Ceased
- 2003-04-28 ES ES03726554T patent/ES2375356T3/es not_active Expired - Lifetime
- 2003-04-28 PT PT03726554T patent/PT1499321E/pt unknown
- 2003-04-28 NZ NZ536248A patent/NZ536248A/en not_active IP Right Cessation
- 2003-04-28 JP JP2004500971A patent/JP2005526843A/ja not_active Withdrawn
-
2004
- 2004-10-24 IL IL164793A patent/IL164793A/en active IP Right Grant
- 2004-11-29 NO NO20045232A patent/NO335006B1/no not_active IP Right Cessation
-
2011
- 2011-03-02 JP JP2011045207A patent/JP2011116771A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003228783A1 (en) | 2003-11-17 |
| MXPA04010705A (es) | 2005-02-17 |
| AU2003228783C1 (en) | 2003-11-17 |
| US20040029849A1 (en) | 2004-02-12 |
| IL164793A0 (en) | 2005-12-18 |
| EP1499321B1 (de) | 2011-10-19 |
| CA2483855C (en) | 2012-01-10 |
| CN100438875C (zh) | 2008-12-03 |
| WO2003092790A2 (en) | 2003-11-13 |
| JP2005526843A (ja) | 2005-09-08 |
| AU2003228783B2 (en) | 2006-11-16 |
| NO20045232L (no) | 2005-01-26 |
| JP2011116771A (ja) | 2011-06-16 |
| PT1499321E (pt) | 2012-02-01 |
| CN1658883A (zh) | 2005-08-24 |
| CA2483855A1 (en) | 2003-11-13 |
| KR100970834B1 (ko) | 2010-07-16 |
| NO335006B1 (no) | 2014-08-25 |
| KR20040105247A (ko) | 2004-12-14 |
| WO2003092790A3 (en) | 2003-12-11 |
| EP1499321A4 (de) | 2008-09-03 |
| NZ536248A (en) | 2007-03-30 |
| US7326697B2 (en) | 2008-02-05 |
| HK1068783A1 (en) | 2005-05-06 |
| EP1499321A2 (de) | 2005-01-26 |
| ES2375356T3 (es) | 2012-02-29 |
| IL164793A (en) | 2012-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL164793A0 (en) | Methods for increasing the therapeutic response toelectroconvulsive therapy ("ect") | |
| TW200510416A (en) | P38 inhibitors and methods of use thereof | |
| DE602004024572D1 (de) | Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen | |
| DE602005023763D1 (de) | Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine | |
| DE69835225D1 (de) | Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen | |
| TNSN07161A1 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
| MY151032A (en) | Treatment of tnf? related disorders | |
| EA200700097A1 (ru) | Производные хиназолин-4-илпиперидина и циннолин-4-илпиперидина в качестве ингибиторов pde10 для лечения расстройств цнс | |
| MY158162A (en) | 5-membered heterocycle-based p38 kinase inhibitors | |
| ATE433973T1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| ATE464303T1 (de) | Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen | |
| ECSP045520A (es) | Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos | |
| TW200504034A (en) | Therapeutic agents | |
| TW200630090A (en) | Triazoles useful as inhibitors of protein kinases | |
| DE69833502D1 (de) | Glucocorticoid receptor antagonisten zur behandlung von demenz | |
| DE602004012578D1 (de) | Als inhibitoren von c-met geeignete pyrrolzusammensetzungen | |
| ATE403433T1 (de) | Adenosin-a1-rezeptorantagonisten zur behandlung von hypoxiebedingten lern- und gedächtnisstörungen | |
| TW200621244A (en) | Modulators of muscarinic receptors | |
| ATE279208T1 (de) | Verfahren und stoffe zur behandlung des prostatakarzinomes | |
| ATE302002T1 (de) | Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit | |
| NO20065297L (no) | Anvendelse av GPCR54 ligander til behandling av infertilitet | |
| ATE522230T1 (de) | Biphenyle als bilderzeugungsmittel bei der alzheimerschen krankheit | |
| MXPA05011699A (es) | Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior. | |
| MXPA05008347A (es) | Composicion que comprende una combinacion de un inhibidor de aromatasa, una progestina y un estrogeno y su uso para el tratamiento de endometriosis. | |
| DE59809283D1 (de) | Inhibitoren für den urokinaserezeptor |